FDA Widens Investigation Into AstraZeneca COVID-19 Vaccine

The transcript discusses the pause in AstraZeneca's COVID-19 vaccine trials after two participants fell ill. The FDA is reviewing data from earlier studies to check for similar side effects. An independent study suggests the side effects are unlikely linked to the vaccine. Trials have resumed in several countries, and AstraZeneca is working with the FDA to resume US trials. The CEO expects the vaccine to be ready by the end of the year.

What was the reason for the pause in AstraZeneca's late-stage studies?

What did AstraZeneca's CEO say about the COVID-19 vaccine timeline?